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Abstract
Objectives: Monitoring of iodine status during pregnancy, lactation and infancy is
difficult as there are no established reference criteria for urinary iodine concentration
(UI) for these groups; so it is uncertain whether iodized salt programs meet the needs
of these life stages.
Design and Subjects: The method used in this paper was: 1) to estimate the median UI
concentration that reflects adequate iodine intake during these life stages; and 2) to
use these estimates in a review of the literature to assess whether salt iodisation can
control iodine deficiency in pregnant and lactating women, and their infants.
Results: For pregnancy, recommended mean daily iodine intakes of 220-250 mg were
estimated to correspond to a median UI concentration of about 150 mg l21, and larger
surveys from the iodine sufficient countries have reported a median UI in pregnant
women $140 mg l21. Iodine supplementation in pregnant women who are mild-to-
moderately iodine deficient is beneficial, but there is no clear affect on maternal or
newborn thyroid hormone levels. In countries where the iodine intake is sufficient,
most mothers have median breast milk iodine concentration (BMIC) greater than the
concentration (100-120 mg l21) required to meet an infant’s needs. The median UI
concentration during infancy that indicates optimal iodine nutrition is estimated to be
$100 mg l21. In iodine-sufficient countries, the median UI concentration in infants
ranges from 90-170 mg l21, suggesting adequate iodine intake in infancy.
Conclusions: These findings suggest pregnant and lactating women and their infants
in countries with successful sustained iodised salt programs have adequate iodine
status.
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Introduction
Iodine deficiency (ID) causes a broad range of adverse
effects on health resulting from the inadequate production
of thyroid hormone that are collectively termed ID
disorders (IDD). An ID during pregnancy increases the
risk of spontaneous abortion, low birth weight and infant
mortality1–5 as well as raising the risk of neuromotor,
behavioural and cognitive impairment in the offspring6–8.
Even a mild-to-moderate ID during pregnancy can cause
transient hypothyroidism, can increase the thyroid
volume in mothers and their infants, and may impair
cognition9–13. During infancy, an adequate amount of
iodine is required for normal mental development12,13;
a meta-analysis estimated that ID in a population lowered
mean IQ scores by 13.5 points14. It is for these reasons that
IDD control programmes should focus on pregnancy,
lactation and infancy, the stages in life when iodine
requirements are at their greatest.
However, the assessment of iodine status during these
life stages is challenging. The main indicator in a
population of a response to salt iodisation is the median
urinary iodine (UI) concentration15, but there are no
established reference values for the median UI concen-
tration during pregnancy, lactation or infancy. A median
concentration of iodine in the range of 100–199mg l21 in
the urine of school-aged children and in non-pregnant,
non-lactating adults indicates an adequate iodine intake
and optimal iodine nutrition15. This range has not been
validated to reflect an adequate iodine status in pregnant
and lactating women or in infants and, as discussed below,
if applied to these target groups is likely to underestimate
the true degree of ID. Most large systematic surveys of ID
have been done in school-aged children or in the general
adult population, and have only rarely included pregnant
or lactating women, or infants. Many of the studies on
pregnant women and infants have comprised only small
numbers, and sampling has rarely been representative,
making it difficult to draw firm conclusions. Despite this,
there is some concern over whether iodised salt
programmes meet the needs of these life stages. There-
fore, the general objectives of this paper are to:
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1. Review the current recommended iodine intake in
pregnancy, lactation and infancy.
2. Estimate the median UI concentration that reflects an
adequate iodine intake during these life stages.
3. Use the estimates of an adequate UI concentration to
assess whether current approaches to salt iodisation
and iodine supplementation can control ID in pregnant
and lactating women, and in their infants.
Methods used to estimate the requirement for iodine
There are three main ways of estimating how much iodine
is required to meet daily needs.
Iodine turnover
The daily uptake and turnover of radioactive iodine can be
used to estimate the requirement for iodine, provided that
the subjects being tested have an adequate iodine status
and are euthyroid16–18.
Iodine balance
Several studies have estimated iodine requirements from
balance experiments19–23, but they have serious limi-
tations. This is mainly because many ingested substances
contain unrecognised iodine, so that a strict control of
iodine intake is difficult to achieve. Because of the need to
consider the iodine content of the thyroid gland, in
addition to iodine intake and excretion, even during
prolonged balance studies, an equilibrium may not clearly
be established19.
Urinary iodine concentration and thyroid size
Since .90% of dietary iodine eventually appears in the
urine23,24, the concentration of iodine in urine is an
excellent indicator of recent iodine intake. An increase in
thyroid size is the earliest clinical sign of impaired iodine
nutrition and reflects an adaptation to the threat of
hypothyroidism.
Definitions of recommendations for iodine intake
The United States Institute of Medicine (IOM) has
proposed several categories of reference intake25. The
recommended dietary allowance (RDA) is the average
daily iodine intake sufficient to meet the iodine require-
ment of about 97% of healthy individuals in a particular life
stage. It is intended to be used as a goal for the daily intake
of iodine by individuals.
The RDA is based on the estimated average requirement
(EAR) which is the daily iodine intake, defined by specific
criteria, that meets the requirement of half of the healthy
individuals in a particular life stage. It assumes a normal
distribution of intake. The RDA is derived from the EAR
after taking into consideration the estimated variability in
individual requirements. The EAR is not meant to be used
to define the intake of individuals, but can be used for
groups.
The adequate intake (AI) can be given if there is not
enough scientific evidence to calculate an EAR. For
example, the AI of iodine during infancy is based on
observed mean iodine intakes by healthy, full-term,
breast-fed infants in areas where iodine intake is known
to be sufficient. The AI is expected to meet or exceed the
amount of iodine needed in almost all individuals in the
specified population group, and can be used as a goal for
individual intake.
According to the WHO, UNICEF and the ICCIDD, the
recommended iodine intake is the amount estimated to
cover the needs of nearly all healthy individuals in the
specified life stage15.
Iodine requirements
Non-pregnant women
Studies of iodine turnover, radioiodine uptake by the
thyroid and balance studies of euthyroid adults have
suggested that the average daily requirement for iodine is
91–96mg per day16,17,20. There is no evidence to suggest
that the average iodine requirement of adults varies with
age25. Thus, the IOM have set the EAR of iodine by women
$14 years at 95mg per day25. The RDA, which is defined
as the EAR plus twice the coefficient of variation of intake
of the population and then rounded to the nearest 50mg, is
150mg day21 for females$14 years25. This amount agrees
with the WHO, UNICEF and the ICCIDD recommended
daily iodine intake for non-pregnant women of 150mg per
day15. These amounts are summarised in Table 1.
Pregnant women
The iodine requirement during pregnancy increases for
three reasons: (1) an increase in the production of
thyroxine (T4) by the mother to maintain her euthyroid
state and transfer thyroid hormone to the foetus; (2) the
transfer of iodine to the foetus, particularly in late gestation
and (3) an increase in renal iodine clearance (RIC) by the
mother26,27. The amount of iodine accumulated by
the infant at the time of delivery has been used to estimate
the daily foetal iodine uptake. The average iodine content
of the thyroid gland of a newborn is 50–100mg, with
.95% daily iodine turnover28,29. Balance studies have
found that the average iodine retention of full-term infants
is 6.7mg kg21 per day30, so the mean retention of iodine by
a healthy foetus with a weight of 3 kg would be about
22mg day21. An estimated daily iodine uptake by the
thyroid gland of about 75mg day21 by the foetus and an
EAR of 95mg day21 for non-pregnant women would yield
an EAR of 170mg day21 during pregnancy. The balance
studies of Delange et al. suggest an EAR of
22 þ 95 ¼ 117mg per day30. Dworkin et al. found that
five pregnant women were in iodine balance when
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consuming about 160mg day21, with no significant
differences pre- and post-partum19. Several authors have
measured the thyroid volume during pregnancy and
correlated it with the UI concentration and the effects of
iodine supplements. In the studies of Romano et al.31 and
Pedersen et al.9, total daily iodine intakes of about 200 and
250–280mg, respectively, during pregnancy prevented an
increase in thyroid volume, while in the study of Glinoer10,
a total daily iodine intake of about 150mg was insufficient
to prevent an increase in thyroid size. On the basis of these
data, the IOM set the EAR at 160mg day21 for pregnancy in
women$14 years, and set the RDA, estimated to be 140%
of the EAR rounded to the nearest 10mg, at 220mg per
day25. The WHO, UNICEF and the ICCIDD recommend a
daily iodine intake of 200mg day21 for pregnant women, a
value 10% lower than the RDA15 (see Table 1).
Lactating women
If a lactating woman produces an average of 0.78 and
0.60 l of milk per day during the first and second 6 months
of infancy, respectively25, and if the mean breast milk
iodine concentration (BMIC) is 146mg l21 in iodine-
sufficient women in the USA, the average daily loss of
iodine in breast milk has been estimated to be about
114mgper day25. When this amount is added to the EAR of
non-pregnant women of 95mg day21, the EAR for lactating
women $14 years is estimated by the IOM to be 209mg
per day25. The RDA is thus 140% of the EAR rounded to the
nearest 10mg, which is 290mg day21 of iodine. The WHO,
UNICEF and the ICCIDD recommend a daily iodine intake
of 200mg day21 by lactating women15, which is similar to
the EAR but 30% lower than the RDA (see Table 1).
Infancy (0–12 months)
Since no functional criteria are available that reflect iodine
intake in infants, recommended intakes are based on the
mean iodine intake of healthy full-term infants fed on
human milk. The IOM based their recommendation on the
median BMIC of women in the United States of America
(USA) in the early 1980s, which was 146mgper l25. Since
the iodine intake of the population of the USA was
relatively high at this time32, this BMIC is at the upper end of
the range of 78–167mg l21 reported for women in iodine-
sufficient countries (see later discussion). Based on
estimates of the mean daily volume of breast milk, the
mean amount of iodine secreted in humanmilk is estimated
to be about 115mg per day25. Balance studies of full-term
infants given 20mg kg21 day21 of iodine found that the
total amount excreted was 12.7mg kg21 day21 and the
amount retainedwas 7.3mg kg21 per day30. If the reference
body weight of an infant aged 6 months is 7 kg25, the daily
amount of iodine excreted by an infant in positive balance
is 90mg. Considering these data, the recommended AI of
iodine for infants aged 0–6 and 6–12 months has been set
at 110 and 130mg day21, respectively, by the IOM25. The
WHO, UNICEF and the ICCIDD recommend a daily iodine
intake of 90mg day21 for infants15, which is 20–30% lower
than the RDA (see Table 1).
Iodine intakes in pregnancy and the effects of iodine
supplementation
Pregnancy
The WHO, UNICEF and the ICCIDD recommend using the
median UI concentration to assess the iodine nutrition of
populations15. The daily iodine intake can be extrapolated
from the UI if it is assumed that girls aged 7–15 years
produce 0.9ml urine h21 per kg33, and adult women
produce about 1.5 l per day34. If it is assumed that the
mean bioavailability of iodine is 92%, the recommended
daily iodine intakes during pregnancy of 20015 and
220mg25 would correspond to a UI concentration of
120–135mg l21 in pregnancy. As pregnancy may occur
in adolescence, particularly in developing countries, a
15-year-old girl weighing some 50 kg with a daily iodine
intake of 200 or 220mg would have a UI concentration of
170–190mg l21.
However, during pregnancy, it may be less valid to
estimate the iodine intake from the UI concentration due
to an increase in the glomerular filtration rate35 and,
Table 1 The intake of iodine by women of child-bearing age, pregnant and lactating women, and
infants recommended by the WHO, UNICEF and the ICCIDD15 and by the United States Institute of
Medicine25.
Authority Life stage Basis of amount mg day21
WHO, UNICEF, ICCIDD Children 0–59 months 90
Women .12 years 150
Pregnant and lactating women 200
United States Institute of Medicine Infants 0–6 months AI 110
Infants 7–12 months AI 130
Women $14 years EAR 95
Women $14 years RDA 150
Pregnancy EAR 160
Pregnancy RDA 220
Lactation EAR 209
Lactation RDA 290
AI, adequate intake; EAR, estimated average requirement; RDA, recommended daily allowance.
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possibly, an increase in RIC36. If the RIC increases during
pregnancy, the daily iodine intake extrapolated from the
UI concentration in pregnancy would be lower than that in
non-pregnancy. However, the evidence for an increase in
RIC and a consequent decrease in the plasma inorganic
iodide (PII) concentration during pregnancy is equivocal.
The study of Aboul-Khair et al. suggested an increase in
RIC using an indirect method36, while Liberman et al.
directly measured the PII concentration and reported no
significant difference in PII or UI concentration both pre-
and post-partum in 16 women living in a population with a
high iodine intake37. The iodine balance study of Dworkin
et al. also found no differences in the UI concentration
both pre- and post-partum19. Owing to the lack of clear
data, it is uncertain whether pregnancy per se significantly
increases the UI concentration. Therefore, in this review,
the above extrapolations from UI concentration to daily
iodine intake proposed by the IOM25 were considered
valid, and the recommended daily intakes of 200–220mg
of iodine15,25 were considered to correspond to a median
UI concentration of 125–135mg l21 in adult pregnant
women, although a higher median of about 170–
180mg l21 may be more appropriate if pregnancy occurs
in early adolescence. Although more data are clearly
needed, a median UI concentration in pregnant women
$140mg l21 has been used in this review as an indicator of
adequate iodine intake.
Table 2 compares the UI concentration of pregnant
women with the general population in countries with
iodine intakes ranging from excessive to deficient. Most
studies analysed spot urine samples and few had an
adequate power to classify iodine status based on a
median UI concentration from such samples38. Few
studies have compared the UI concentration of pregnant
women with a control group of non-pregnant women.
As shown in Table 2, the UI concentration in pregnant
women and in the general population generally appear
to be similar. However, this may be due to a
preponderance of studies in areas where there is low
or marginal iodine sufficiency, as several studies in
iodine-sufficient countries have found a significantly
higher median UI concentration in pregnant
women39–43. All of the large studies in iodine-sufficient
countries have reported a median UI concentration in
pregnant women of $140mg l21. This includes countries
where all salt is iodised (Switzerland and Iran), and
countries where dietary iodine comes from either iodised
salt or from other food sources (USA, UK, Sri Lanka and
Sweden). If a median UI concentration $140mg l21 in
pregnant women is taken to represent a mean iodine
intake $200mg day21, then it appears that the iodine
status of pregnant women is adequate in countries where
the general population is adequately covered either
wholly or partially by iodised salt programmes.
Studies of thyroid size in pregnant women support
these data. As shown in Table 3, in countries affected by
mild or moderate ID (Ireland, Germany, Belgium, Italy
and Denmark), the thyroid volume increases 15–31%
during pregnancy, while in iodine-sufficient countries
(Finland, USA and The Netherlands), there is little or no
increase in thyroid volume during pregnancy44. This
suggests that iodine status is adequate in pregnant
women in iodine-sufficient countries with two important
caveats. First, the question remains unanswered of
whether RIC changes enough during pregnancy to
confound the usual estimation of iodine intake based on
the median UI concentration. Second, iodine-containing
supplements taken during the prenatal period may have
led to an increased median UI concentration in pregnant
women living in countries with an iodised salt
programme45.
Iodine supplements during pregnancy and their
impact on iodine status
In Europe, 13–50% of women receive iodine-containing
supplements during pregnancy45. In a study of 511
pregnant Swiss women in 1999, although 70% received a
prenatal supplement, only 13% received a supplement
containing iodine; the median UI concentration in the
women taking iodine-containing supplements was 194 vs.
130mg l21 in non-supplemented women42. After a 33%
increase in the concentration of iodine in salt, a study of
276 pregnant Swiss women in 2004 reported a median UI
concentration of 254mg l21; there was no significant
difference in the median UI concentration of women
taking iodine-containing supplements compared with
those who were not43.
In a recent study of 109 pregnant German women, the
median UI concentration was 181mg g21 creatinine (cr.);
58%were taking iodine-containing supplements and had a
significantly higher UI concentration (204mg g21 cr.) than
women who were not (148mg g21 cr.)46.
In earlier studies of women in Denmark47 and
Germany48, the median UI concentration was significantly
higher in pregnant women supplemented with iodine than
women not supplemented: 58 vs. 35mg day21 in Denmark
and 85 vs. 59mg day21 in Germany.
In Hungary, about 50% of pregnant women receive a
supplement containing iodine. In those women taking
supplements containing $150mg iodine per day, the
median UI concentration was 115–130mg g21 cr., com-
pared with 57–68mg g21 cr. in women who were not
supplemented49.
In a cross-sectional study in Denmark, the use of
iodine supplements of 150mg day21 and thyroid function
were assessed in 144 pregnant women and their
newborns50. At full term, the median UI concentration
of supplemented mothers was 60mg l21 compared with
35mg l21 in unsupplemented mothers. In the sup-
plement group, the concentration of thyroglobulin (Tg)
in both maternal and cord blood was significantly lower,
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and the free T4 concentration was significantly higher,
than in unsupplemented women44. Although the
maternal TSH concentration was lower in the sup-
plement group, the cord TSH concentration was 27%
higher in the supplement group50, suggesting that
in iodine-deficient areas, the foetal thyroid gland
may be particularly sensitive to the inhibitory effect of
iodine.
Table 2 Urinary iodine concentration1–3 of pregnant women in longitudinal (L) and cross-sectional (C) studies and, if available, in
the general population or in non-pregnant controls. The urinary iodine concentration in the post-partum period is shown if a longi-
tudinal study continued after delivery.
Reference
Iodine status
Country n L or C
Trimester of pregnancy
or time post-partum (PP)
Urinary iodine
concentration
General population
or controls
Iodine excess
37 Chile 19 L 1 5941
19 L 2 4691
19 L 3 7861
19 L 3 months PP 4591
Iodine sufficient
67 Iran 403 C 1,2,3 186–3382 193–3122
40 Sri Lanka – C 1 1812 1472
C 2 1362
C 3 1542
68 Sweden 51 L 1 1801
51 L 2 1701
51 L 3 1451
42 Switzerland 511 C 2, 3 1382 1152
69 Switzerland 153 C 1,2,3 2053 913
43 Switzerland 281 C 1,2,3 2542 1292
40 UK – C 1 1252 732
C 2 1702
C 3 1472
70 USA 290 C 1,2,3 1481 1301
11,41 Singapore 253 C 3 1242 982
230 L 1 1072
2 1162
3 1242
6 weeks PP 1052
3 months PP 1042
Iodine deficient
71 Belgium 334 C 1,2 502 50–751
334 C 2,3 452
136 C 1 562
133 C 2 502
49 C 3 502
9 Denmark 26 L 2 512 501
26 L 3 402
26 L 1 week PP 302
26 L 26 weeks PP 502
26 L 52 weeks PP 582
72 France 306 L 1 502 50–801
224 L 3 542
39,40 Ireland 38 L 1 1352 702
38 L 2 1252
38 L 3 1222
53 Italy 67 C 1,2 743
31 Italy 18 C 3 501
54,73 Italy 10 L 1,2,3 331 461
51 Germany 70 L 1 553
70 L 11 days PP 503
46 Germany 109 C 1,2,3 1813
49 Hungary 119 C 1,2,3 573
74 New Zealand 35 L 1,2,3 and 3,6,12 months PP 24–521 24–471
75 Nepal 1021 C/L 1,2,3 961
1028 C/L 13 weeks PP 611
76 Sudan 47 L 3 382 762
47 L 3 months PP 512
47 L 6 months PP 302
47 L 9 months PP 632
77 Turkey 80 L 1,2,3 911 851
1mg day21; 2mg l21; 3mg g21 creatinine.
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Table 4 shows results from six randomised, controlled
trials of iodine supplementation involving 450 pregnant
European women with mild-to-moderate ID.
Romano et al.31 gave 120–180mg iodine as iodised salt
daily or gave a placebo control beginning in the first
trimester to healthy pregnant women (n ¼ 35, median UI
concentrations in the two groups 31 or 37mg l21). In the
group treated with iodine, the median UI concentration
increased threefold and thyroid volume did not change31.
In the controls, there was no change in the UI
concentration, and had a 16% increase in thyroid
volume31. Treatment had no effect on the maternal TSH
concentration.
Pedersen et al.9 randomised 54 pregnant women to
receive either 200mg iodine per day as a solution of
potassium iodide or no supplement from 17 weeks of
pregnancy to full term. The median UI concentration
increased from 55 to 90–110mg l21 in the treated group.
The thyroid volume of women increased 16% in
the treated group compared with 30% in the controls9.
The concentration of Tg and TSH in women, and the
concentration of cord Tg, were significantly lower in
the treated group than in the controls9. No significant
differences were found between groups in terms of the
concentration of T4, T3 and fT4 in maternal or cord
blood9.
In a double-blind, placebo-controlled trial, Glinoer
et al.10 supplemented 120 pregnant women who had a
median UI concentration of 36mg l21 and biochemical
criteria of excess thyroid stimulation, with 100mg iodine
per day or gave a placebo control from around 14 weeks
of pregnancy to full term. The treatment had no significant
effect on the concentration of maternal or cord T3, fT4 and
the T3/T4 ratio
10. The treated women had a significantly
higher UI concentration, a smaller thyroid volume and a
lower concentration of TSH and Tg when compared with
controls10. The newborn children of the treated group also
had significantly higher UI concentration, a smaller thyroid
volume and a lower Tg concentrations when compared
with controls10. There was a 14% increase in the cord
serum TSH concentration in the treated group, but it was
not statistically significant.
Liesenko¨tter et al.51 reported a quasi-randomised,
controlled trial of 230mg iodine per day given from the
eleventh week of pregnancy to full term in 108
pregnant women with a median UI concentration of
53mg g21 cr. and a goitre rate of 42.5%. The median UI
concentration increased to 104mg g21 cr. in the treated
group, and the median thyroid volume was significantly
lower in the newborns of the treated women compared
with controls (0.7 vs. 1.5ml, respectively)51. Treatment
had no significant effect on the concentration of
maternal TSH, T3, T4, Tg or on the thyroid volume,
and had no effect on the concentration of TSH in the
newborn51.
In a placebo-controlled, double-blind trial, Nohr et al.52
gave to 66 pregnant women who had antibodies to anti-
thyroid peroxidase (TPO-Ab) a multi-nutrient supplement
containing 150mg iodine per day or a placebo control
from the eleventh week of pregnancy to full term. The
median UI concentration was significantly higher in the
treated women at full term than in the controls, but there
were no differences in the concentration of maternal TSH,
fT4 or Tg between groups
52. There was no difference in
the prevalence of anti-thyroglobulin antibodies (Tg-Ab) or
TPO-Ab, and no differences between groups in the
prevalence or severity of post-partum thyroid dysfunction
(PPTD), defined as an abnormal TSH concentration in the
Table 4 Randomised, controlled trials of iodine supplementation
during pregnancy in mild-to-moderate iodine-deficient countries of
Europe and the urinary iodine concentration before and after
treatment.
Urinary iodine concentration
Reference
Iodine dose
(mg day21)
Before
treatment After treatment
53 50 651 1281
10 100 362 80–902
31 120–180 373 1003
52 150 502 1052
9 200 552 90–1102
53 200 911 2301
51 230 531 1041
1mg g21 cr.; 2mg l21; 3mg day21.
Table 3 Changes in thyroid size measured by ultrasound during pregnancy in iodine-sufficient and -deficient countries.
Reference
Iodine status
Country n
Trimester (T) of pregnancy
or time post-partum (PP) Change in thyroid size
Iodine sufficient
78 Finland 7–21 1,2,3 T No or small increase during pregnancy
79 Netherlands 10 Before pregnancy, 1,2,3 T No increase during pregnancy
80 USA 16 3 T and 6 months PP 13% decrease after parturition
Iodine deficient
71 Belgium 33–172 1,2,3 T and 6 months PP 18% increase during pregnancy
10 Belgium 60 1,3 T 30% increase during pregnancy
81 Denmark 20 2,3 T and 3,6,12 months PP 20% increase during pregnancy
9 Denmark 24–26 2,3 T and 3,6 months PP 31% increase during pregnancy
82 Ireland 14–95 1,2,3 T and 6,12 months PP 15% increase during pregnancy
31 Italy 18 1,3 T 16% increase during pregnancy
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post-partum period. However, 12/20 (60%) treated
women developed PPTD compared with 11/24 (46%)
controls, and failure to detect a significant difference
in the prevalence of PPTD may have been due to a type
II error.
In a prospective, randomised, open-label trial,
Antonangeli et al.53 supplemented 67 pregnant women
who had a median UI concentration of 74mg g21 cr. with
50 or 200mg iodine per day from 18–26 weeks of
pregnancy to 29–33 weeks. The median UI concen-
tration was significantly higher in group given 200mg
iodine per day than in the group given 50mg iodine per
day (230 vs. 128mg g21 cr.).53 However, there were no
differences between groups in the concentration of
maternal fT4, fT3, TSH and Tg or in thyroid volume, and
no differences in the prevalence of TPO-Ab, Tg-Ab or
PPTD.
In summary, in all of these trials, iodine supplements
significantly increased the maternal UI concentration.
The doses of iodine varied between 50 and
230mg day21, and the data indicate no clear dose–
response relationship for the concentration of UI, TSH,
Tg, thyroid hormones or in terms of thyroid volume.
Iodine supplements during pregnancy generally appear
to be safe; there was no increase in the trials the
prevalence of thyroid autoimmunity in mothers, or in the
prevalence or severity of PPTD. However, the sample
sizes were small and more data, particularly from TPO-
Ab þ women, would be valuable. In three of the five
trials that measured the thyroid volume of mothers,
supplementation was associated with a significantly
reduced thyroid size. The studies also suggest that an
increase in newborn thyroid volume and the concen-
tration of Tg can be prevented or minimised by iodine
supplementation. Although less consistent, the data also
suggest that the concentration of maternal TSH is
generally lower (within the normal reference range) with
supplementation. Supplementation has little or no
impact on the concentration of total or free thyroid
hormones in mothers and newborn children. There are
no clinical data on the effect of supplementation on birth
weight or prematurity, and no data on long-term
outcomes, such as maternal goitre, thyroid autoimmunity
or child development.
Iodine intakes during lactation and urinary iodine
and breast milk iodine concentrations
Since the mammary gland is able to concentrate iodine,
the iodine supply to the newborn via the breast milk may
be maintained even in the face of a maternal ID54,55. This
may help explain why, in areas where there is an ID, BMIC
is often greater than expected based on the UI
concentration of lactating mothers55,56. The BMIC is
strongly influenced by the mothers’ iodine intake58.
In the USA, Gushurst et al.57 found that the median
BMIC in women who consumed uniodised salt was
113mg l21, while the median concentrations in women
who consumed low or high amounts of iodised salt were
143 or 270mg l21, respectively.
Several studies have compared the BMIC before and
after supplementation with iodised oil or potassium
iodide, or with untreated controls.
Pretell et al.59 injected women with 950mg iodine as
iodised oil. The median BMIC at 18–36 months post-
partum was 70mg l21 compared with 2mg l21 in mothers
not receiving treatment.
In Algeria, Chaouki and Benmiloud60 gave 240mg
iodine as oral iodised oil either 1–3 months before
pregnancy or in the first or third trimester. At delivery and
6 month post-partum, the mean BMIC ranged from 520 to
559mg l21 and from 307 to 346mg l21, compared with 307
and 260mg l21 in untreated women.
In 147 Danish mothers, the median BMIC on the fifth
day post-partum was significantly higher (57mg l21) in
those receiving supplementation with 150mg day21 of oral
iodine, compared with women who were not sup-
plemented (34mg l21)61.
In Germany, 60 mothers who received 200mg day21 of
oral iodine had a significantly higher mean iodine
concentration in breast milk (76mg l21) than untreated
controls (55mg l21)62.
Although increasing the iodine intake of iodine-
sufficient women can further increase BMIC57, an iodine
intake by an infant that is greater than requirements will
simply be excreted in the urine. Thus, iodine requirements
during lactation should be based on infant balance studies
rather than on the measured but variable amount of iodine
excreted in breast milk by women in iodine-sufficient
countries. Based on the balance studies of Delange et al.30,
the full-term infant’s requirement for iodine is about
90mg day21, and this is the intake recommended by the
WHO, UNICEF and the ICCIDD15. Based on a mean breast
milk volume of 0.78 l day21 in the first 6 months of
infancy25, and assuming that 95% of the iodine in breast
milk is absorbed, a BMIC of $120mg l21 should cover the
infant’s iodine requirement of 90mg day21 until weaning
foods are begun. Most infants begin weaning by the
second half of the first year of life, and some of the iodine
requirement during that period will be met from weaning
foods. Semba and Delange58 proposed that a potential
indicator of iodine status in a population could be the
proportion of lactating women whose BMIC is
$100mg l21.
Table 5 shows the BMICs of women living in areas
where people are iodine sufficient or have mild-to-
severe ID. Among the iodine-sufficient countries, the
BMICs of women in Switzerland and Sweden are less
than the concentration required to meet an infant’s
needs (100–120mg l21), while they are at, or above,
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this concentration in the Netherlands, the USA and
Japan.
Although the requirement for iodine of a mother is
large at 200–290mg day21, after accounting for iodine
losses in breast milk, the median UI concentration of
lactating women that indicates adequate iodine nutrition
should be similar to that of non-pregnant, non-lactating
women, i.e. 100–199mg per l15. Table 6 shows the UI
concentrations reported from studies of lactating women
in iodine-sufficient and -deficient countries. There are
few data, the numbers of women in most studies are
small, and breast-feeding status was often not clearly
documented. The studies generally report a median UI
concentration in lactating women that is similar to the
general population, but almost all reports are from
iodine-deficient countries, and show median UI concen-
trations ,100mg l21.
Iodine intakes during infancy
During infancy, the mean volume of breast milk consumed
is about 0.78 l day21 over the first 0–6 months25 and some
60–65% of ingested water is excreted by the kidney63.
Although there is a large day-to-day variation, the volume
of urine daily in early infancy is estimated to be 30–
55ml kg21 body weight63–65 and the reference body
weight for a child aged 0–6 months is 7 kg and for a child
aged 6–12 months is 9 kg25. Based on these data, the
volume of urine is estimated to be 0.4–0.5 l day21 in early
infancy. Therefore, considering the requirement for iodine
of 90mg per day15, the median UI concentration indicating
optimal iodine nutrition in infancy is estimated to be in the
range of $180–220mg per l26.
Delange et al.66 supplemented healthy infants and
children aged 6 months to 3 years in Belgium who had a
median UI concentration at baseline of 101mg l21, with an
dose of 90mg day21 of iodine. After about 30 days of
supplementation, the geometric mean UI concentration
was beginning to plateau at 220–240mg l21.
Table 7 shows the median UI in full-term newborns in
countries with iodine sufficiency and varying degrees of
ID. In general, among the iodine-sufficient countries, the
median UI concentration varies from 96 to 167mg l21,
well below the estimated median UI concentration of
$180–220mg l21 that indicates an adequate iodine
intake. More data are clearly needed, but the evidence
available suggests that the iodine intake of many infants,
even in countries designated as iodine sufficient, may be
suboptimal.
Table 5 The mean or median breast milk iodine concentration of
women in iodine-sufficient and -deficient countries.
Iodine sufficient
Reference Country mg l21
83 Finland 25–53
84 Japan 661
85 Japan 33–385
86 New Zealand 98–247
87 The Netherlands 10
88 Saudi Arabia 136–198
89 Saudi Arabia 149–204
90 South Korea 892
91 Sweden 93
92 Sweden 56
93 Switzerland 78
57 USA 60
94 USA 113–270
95 USA 142
Iodine deficient
96 Australia 50
97 Belgium 54
91 Belgium 95
98 Ethiopia 5–16
99 France 74
100 France 70
101 France 82
102 Germany 7
103 Germany 55
91 Germany 25
104 Germany 93
105 Germany 18–25
106 Germany 30–34
92 Guatemala 60
92 Hungary 64
107 Italy 150
108 Italy 59
54 Italy 33–43
109 Morocco 27–40
110 Niger 40
92 Nigeria 62
92 Philippines 57
111 Reunion 18–54
112 Slovakia 81–89
113 Spain 100
114 Spain 109
115 Spain 77–100
116 Thailand 45–68
117 Turkey 109
56 Turkey 73
92 Zaire 15
Table 6 Urinary iodine concentration1–3 in lactating women and
in the general population or in non-lactating controls in countries
of different iodine status.
Reference
Iodine status
Country n
Time
post-partum
Urinary
iodine
General
population
or controls
Iodine excess
37 Chile 19 3 months 4591
Iodine sufficient
41 Singapore 230 6 weeks 1052 982
3 months 1042
Iodine deficient
9 Denmark 26 1 week 302 501
26 26 weeks 502
26 52 weeks 582
39 Ireland 108 6 weeks 702 702
51 Germany 70 11 days 503
74 New Zealand 35 3,6,12 months 24–521 24–471
75 Nepal 1028 13 weeks 611
76 Sudan 47 3–9 months 30–632 762
56 Turkey 70 5 days 302
1mg day21; 2mg l21; 3mg g21 creatinine.
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